Ray Y. Chen

4.2k total citations
44 papers, 1.9k citations indexed

About

Ray Y. Chen is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Ray Y. Chen has authored 44 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Infectious Diseases, 25 papers in Epidemiology and 17 papers in Virology. Recurrent topics in Ray Y. Chen's work include HIV/AIDS Research and Interventions (24 papers), HIV Research and Treatment (17 papers) and HIV/AIDS drug development and treatment (17 papers). Ray Y. Chen is often cited by papers focused on HIV/AIDS Research and Interventions (24 papers), HIV Research and Treatment (17 papers) and HIV/AIDS drug development and treatment (17 papers). Ray Y. Chen collaborates with scholars based in United States, China and South Africa. Ray Y. Chen's co-authors include Yan Zhao, Fujie Zhang, Ye Ma, Zhihui Dou, James L. Raper, Michael S. Saag, Clifton E. Barry, Marc Bulterys, Guowei Ding and Yao Zhang and has published in prestigious journals such as Nature Medicine, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Ray Y. Chen

43 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ray Y. Chen United States 26 1.5k 1.0k 572 269 197 44 1.9k
Beverly E. Sha United States 29 828 0.5× 1.1k 1.1× 722 1.3× 63 0.2× 226 1.1× 84 2.4k
Susan E. Buskin United States 24 1.4k 0.9× 1.2k 1.2× 397 0.7× 200 0.7× 135 0.7× 74 2.0k
Tsehaynesh Messele Ethiopia 24 962 0.6× 609 0.6× 515 0.9× 125 0.5× 107 0.5× 64 1.8k
Melissa Krone United States 17 872 0.6× 566 0.6× 862 1.5× 163 0.6× 287 1.5× 25 1.7k
M. V. O'Shaughnessy Canada 23 1.3k 0.9× 1.2k 1.2× 592 1.0× 200 0.7× 165 0.8× 56 2.1k
George N. Liomba United States 29 1.6k 1.0× 1.2k 1.2× 576 1.0× 148 0.6× 304 1.5× 56 3.3k
Lise Werner South Africa 26 1.4k 0.9× 954 1.0× 929 1.6× 117 0.4× 97 0.5× 63 2.4k
Pachamuthu Balakrishnan India 28 1.4k 0.9× 990 1.0× 733 1.3× 156 0.6× 147 0.7× 154 2.3k
Anandi N. Sheth United States 28 1.3k 0.9× 742 0.7× 455 0.8× 202 0.8× 548 2.8× 147 2.2k
Vana Sypsa Greece 32 1.2k 0.8× 2.1k 2.1× 411 0.7× 184 0.7× 36 0.2× 132 3.4k

Countries citing papers authored by Ray Y. Chen

Since Specialization
Citations

This map shows the geographic impact of Ray Y. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ray Y. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ray Y. Chen more than expected).

Fields of papers citing papers by Ray Y. Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ray Y. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ray Y. Chen. The network helps show where Ray Y. Chen may publish in the future.

Co-authorship network of co-authors of Ray Y. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Ray Y. Chen. A scholar is included among the top collaborators of Ray Y. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ray Y. Chen. Ray Y. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Diacon, Andreas H., Clifton E. Barry, Ray Y. Chen, et al.. (2024). A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial. Nature Medicine. 30(3). 896–904. 20 indexed citations
2.
Xie, Yingda L., Lindsey B. Rosen, Irini Sereti, et al.. (2015). Severe Paradoxical Reaction During Treatment of Disseminated Tuberculosis in a Patient With Neutralizing Anti-IFNγ Autoantibodies. Clinical Infectious Diseases. 62(6). 770–773. 18 indexed citations
3.
Liao, Qiaohong, Tian Bai, Lei Zhou, et al.. (2013). Seroprevalence of Antibodies to Highly Pathogenic Avian Influenza A (H5N1) Virus among Close Contacts Exposed to H5N1 Cases, China, 2005–2008. PLoS ONE. 8(8). e71765–e71765. 12 indexed citations
4.
Cheng, Shiming, Wei Chen, Ping Chu, et al.. (2013). Effect of Diagnostic and Treatment Delay on the Risk of Tuberculosis Transmission in Shenzhen, China: An Observational Cohort Study, 1993–2010. PLoS ONE. 8(6). e67516–e67516. 52 indexed citations
5.
Jia, Zhongwei, Lu Wang, Ray Y. Chen, et al.. (2011). Tracking the Evolution of HIV/AIDS in China from 1989–2009 to Inform Future Prevention and Control Efforts. PLoS ONE. 6(10). e25671–e25671. 38 indexed citations
6.
Wang, Xia, Huiqin Li, Shujia Liang, et al.. (2011). Factors Associated with HIV Virologic Failure Among Patients on HAART for One Year at Three Sentinel Surveillance Sites in China. Current HIV Research. 9(2). 103–111. 33 indexed citations
7.
Zhang, Fujie, Zhihui Dou, Ye Ma, et al.. (2011). Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. The Lancet Infectious Diseases. 11(7). 516–524. 221 indexed citations
8.
Dou, Zhan, Ray Y. Chen, Jing Xu, et al.. (2010). Changing baseline characteristics among patients in the China National Free Antiretroviral Treatment Program, 2002-09. International Journal of Epidemiology. 39(Supplement 2). ii56–ii64. 34 indexed citations
9.
Xu, Junjie, Haibo Wang, Yan Jiang, et al.. (2010). Application of the BED capture enzyme immunoassay for HIV incidence estimation among female sex workers in Kaiyuan City, China, 2006–2007. International Journal of Infectious Diseases. 14(7). e608–e612. 18 indexed citations
10.
Bulterys, Marc, Sten H. Vermund, Ray Y. Chen, & Chin‐Yih Ou. (2009). A public health approach to rapid scale-up of free antiretroviral treatment in China: an ounce of prevention is worth a pound of cure.. PubMed. 122(11). 1352–5. 10 indexed citations
11.
Zhou, Lei, Qiaohong Liao, Libo Dong, et al.. (2009). Risk Factors for Human Illness with Avian Influenza A (H5N1) Virus Infection in China. The Journal of Infectious Diseases. 199(12). 1726–1734. 103 indexed citations
12.
Zhang, Fujie, Zhihui Dou, Yu Lan, et al.. (2008). The Effect of Highly Active Antiretroviral Therapy on Mortality among HIV‐Infected Former Plasma Donors in China. Clinical Infectious Diseases. 47(6). 825–833. 85 indexed citations
13.
Zhang, Fujie, Paul D. Bouey, Yan Zhao, et al.. (2007). The Diagnosis and Treatment of HIV-Infected Children in China. JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(4). 429–434. 16 indexed citations
14.
Chen, Ray Y., Andrew O. Westfall, J. Michael Hardin, et al.. (2007). Complete Blood Cell Count as a Surrogate CD4 Cell Marker for HIV Monitoring in Resource-Limited Settings. JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(5). 525–530. 15 indexed citations
15.
Bedimo, Roger, Ray Y. Chen, Andrew O. Westfall, et al.. (2006). Sustained HIV Viral Suppression following Treatment Interruption: An Observational Study. AIDS Research and Human Retroviruses. 22(1). 40–44. 11 indexed citations
16.
Chen, Ray Y., Neil A. Accortt, Andrew O. Westfall, et al.. (2006). Distribution of Health Care Expenditures for HIV-Infected Patients. Clinical Infectious Diseases. 42(7). 1003–1010. 124 indexed citations
17.
Bedimo, Roger, Ray Y. Chen, Neil A. Accortt, et al.. (2004). Trends in AIDS-Defining and Non--AIDS-Defining Malignancies among HIV-Infected Patients: 1989-2002. Clinical Infectious Diseases. 39(9). 1380–1384. 94 indexed citations
18.
Chen, Ray Y., Andrew O. Westfall, Michael J. Mugavero, et al.. (2003). Duration of Highly Active Antiretroviral Therapy Regimens. Clinical Infectious Diseases. 37(5). 714–722. 80 indexed citations
19.
Chen, Ray Y., Andrew O. Westfall, James L. Raper, et al.. (2002). Immunologic and Virologic Consequences of Temporary Antiretroviral Treatment Interruption in Clinical Practice. AIDS Research and Human Retroviruses. 18(13). 909–916. 18 indexed citations
20.
Chen, Ray Y., J Michael Kilby, & Michael S. Saag. (2002). Enfuvirtide. Expert Opinion on Investigational Drugs. 11(12). 1837–1843. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026